Phar Vision Advisers, LLC Inogen Inc Transaction History
Phar Vision Advisers, LLC
- $118 Billion
- Q4 2024
A detailed history of Phar Vision Advisers, LLC transactions in Inogen Inc stock. As of the latest transaction made, Phar Vision Advisers, LLC holds 18,885 shares of INGN stock, worth $201,502. This represents 0.15% of its overall portfolio holdings.
Number of Shares
18,885Holding current value
$201,502% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding INGN
# of Institutions
145Shares Held
20.9MCall Options Held
88.5KPut Options Held
116K-
Camber Capital Management LP Boston, MA2MShares$21.3 Million0.42% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$17.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.46MShares$15.6 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.36MShares$14.5 Million0.3% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN849KShares$9.06 Million0.0% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $244M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...